Modulation of dopamine D3 receptor binding by N-ethylmaleimide and neurotensin
References (23)
- et al.
Isomeric selectivity at dopamine D3 receptors
Eur. J. Pharmacol.
(1993) - et al.
Effect of TRH and dopamine on cyclic AMP levels in enriched mammotroph and thyrotroph cells
Mol. Cell. Endocrinol.
(1978) - et al.
Protein measurement with the folin phenol reagent
J. Biol. Chem.
(1951) - et al.
Pharmacology of human dopamine D3 receptor expressed in a mammalian cell line: comparison with D2 receptor
Eur. J. Pharmacol.
(1992) Biochemical characterization of the intramembrane interaction between neurotensin and dopamine D2 receptors in the rat brain
Brain Res.
(1991)- et al.
Intraventricular injection of neurotensin reduces dopamine D-2 agonist binding in rat forebrain and intermediate lobe of the pituitary gland. Relationship to serum hormone levels and nerve terminal coexistence
Brain Res.
(1990) - et al.
Reactive sulfhydryl groups of a39, a guanine nucleotide binding protein from brain: location and function
J. Biol. Chem.
(1987) - et al.
Neurotensin in vitro markedly reduces the affinity in subcortical limbic [3H]N-propylnorapomorphine binding sites
Acta Physiol. Scand.
(1983) - et al.
Relationship between the inhibition constant (Ki) and the concentration of inhibitor which causes 50 per cent inhibition (IC50) of an enzymatic reaction
Biochem. Pharmacol.
(1973) - et al.
Model systems for the study of seven-transmembrane-segment receptors
Annu. Rev. Biochem.
(1991)
Presynaptic dopamine autoreceptors control tyrosine hydroxylase activation in depolarized striatal dopaminergic terminals
J. Neurochem.
(1986)
Cited by (0)
This work was supported by a grant from the Swedish Medical Research Council (14X-10377-01).
Copyright © 1994 Published by Elsevier B.V.